NCT06286228

Registry of Haploidentical Hematopoietic Stem Cell Transplantation in Adult With Hematologic Disease

Name: Clinical Trial NCT06286228
Creator: Siriraj Hospital
Keywords: Multiple Myeloma, clinical trial

Siriraj Hospital·ClinicalTrials.govNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Multiple Myeloma
Study type: Observational

Sponsor & location

Primary sponsor: Siriraj Hospital

Timeline & enrollment

Phase: N/A
Start date: Apr 01, 2024
End date: Apr 01, 2030
Enrollment: 43 participants

Primary outcome

Summary

The goal of this observational study is to register hematologic patients with haploidentical hematopoietic stem cell transplantation (haploHSCT). The main questions it aims to answer are:  - 1-year progression free survival rate  - 1-year overall survival rate  - Graft-versus-host free relapsed free survival at 30-day, 100-day, 180-day and 1-year  - Chronic Graft-versus-host free relapsed free survival at 180-day and 1-year  - Rate of Neutrophil and platelet engraftment  - Efficacy of donor specific antibody desensitization  - Relapsed rate  - Primary and late graft failure  - Safety and complication of haploHSCT  - Complication of viral, bacterial, and fungal infection  - Viral reactivation  - Comparison outcomes between matched sibling donor (MSD) HSCT and matched unrelated donor (MUD) HSCT  - Comparison cost-effectiveness of treatment between matched sibling donor (MSD) HSCT and matched unrelated donor (MUD) HSCT Participants will be collected the data of baseline diagnosis, treatment, treatment results of all admission and follow-up visits from hospital medical record.

ICD-10 classifications

Multiple myelomaMultiple myeloma and malignant plasma cell neoplasmsOther myeloid leukaemiaMyeloid leukaemiaOther myelodysplastic syndromes

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06286228
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06286228 through Pure Global AI's free database. This phase not specified trial is sponsored by Siriraj Hospital and is currently Not yet recruiting. The study focuses on Multiple Myeloma. Target enrollment is 43 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.